The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues
1997

Study of DNA Topoisomerase Isoforms in Human Tissues

Sample size: 69 publication Evidence: moderate

Author Information

Author(s): H Turley, M Comley, S Houlbrook, N Nozaki, A Kikuchi, I D Hickson, K Gatter, A L Harris

Primary Institution: University of Oxford, John Radcliffe Hospital

Hypothesis

The expression of topoisomerase II isoforms is differentially regulated in normal and neoplastic human tissues.

Conclusion

Topoisomerase IIa is a strict proliferation marker, while topoisomerase IIβ is widely expressed in various tissues, including quiescent cells.

Supporting Evidence

  • Topoisomerase IIa was exclusively expressed in proliferating compartments of normal tissues.
  • High-grade lymphomas and seminomas showed high levels of topoisomerase IIa expression.
  • Topoisomerase IIβ was expressed in all tissue types, including quiescent cells.
  • Colon tumors displayed high levels of topoisomerase IIa despite their intrinsic drug resistance.

Takeaway

This study looked at two types of proteins that help cells divide and found that one type is only present when cells are growing, while the other is found in many types of cells, even when they are not growing.

Methodology

The study used isoform-specific antibodies to analyze the distribution and expression of topoisomerase II isoforms in normal tissues and tumor biopsies.

Limitations

The study may not account for all factors influencing drug resistance in tumors.

Participant Demographics

The study included various human tissues and 69 primary tumor biopsies from different cancer types.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication